Showing results (491-500 of 1,046) with videos related to
Sort By:
Pageof 105
European Journal of Heart Failure|April 24, 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fractionMichael Böhm, Amr Abdin, Jonathan Slawik, et al.Journal of Hypertension|March 17, 2023
Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort studyFelix Götzinger, Thomas Wilke, Fänce Hardtstock, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2023
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologistsAlvar Agusti, Michael Böhm, Bartolomé Celli, et al.European Journal of Heart Failure|March 2, 2026
Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trialsSebastian J Fox, Asgher Champsi, Evan J Hardy, et al.Journal of the American College of Cardiology|December 15, 2010
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developmentsStephan H Schirmer, Magnus Baumhäkel, Hans-Ruprecht Neuberger, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 10, 2018
Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected]Amr Abdin, Janine Pöss, Georg Fuernau, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 2, 2018
Correction to: Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trialAmr Abdin, Janine Pöss, Georg Fuernau, et al.International Journal of Cardiology. Heart & Vasculature|April 14, 2021
Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndromeAnna Lena Hohneck, Peter Fries, Jonas Stroeder, et al.Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.Frontiers in Neurology|May 16, 2022
Ischemic Stroke-A Scientometric AnalysisDominic Millenaar, Andreas Ragoschke-Schumm, Tobias Fehlmann, et al.Pageof 105